Advertisement

Reactions Weekly

, Volume 1178, Issue 1, pp 5–5 | Cite as

Earlier epoetin labelling changes expanded by US FDA

Media release
  • 8 Downloads

Keywords

Chronic Renal Failure Zidovudine Darbepoetin Alfa Boxed Warning Chronic Renal Failure Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    FDA.FDA Strengthens Boxed Warnings, Approves Other Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs). Media Release: 8 Nov 2007. Available from: URL: http://www.fda.gov

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations